XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Winter weather and growing data-center energy use push electricity bills higher than inflation, placing new pressure ...
Analysts see Elon Musk's Terafab strategy as a potential catalyst for chip-equipment makers and select chip stocks, b...
As gold prices stabilize after a broad correction, two gold mining stocks poised for a rebound are drawing fresh inte...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
As debt pressures mount, Ray Dalio warns the stock market may be flirting with bubble-like extremes seen before the 1...
Micron and Intel led a tech selloff that pushed the sector into a correction, amplifying volatility as investors reca...
Prediction markets are signaling a meaningful downside risk for XRP in 2026, with odds centered around a sub-$1 print...
Vishay Precision Group leads the robotics supply chain rally in 2026 with a 216% YTD gain, outpacing Ouster and Aeva....
The S&P 500 trades at 22x forward earnings, but a deeper look at cash flow reveals a 32x multiple, driven by AI-relat...
Ethereum fails to sustain a rebound toward the $2,000 level as a fresh pullback tests support and resistance dynamics...
A simple on-screen warning can open a doorway to financial ruin. This article unpacks a real-world fake Microsoft ale...